Buscar resultados de ensayos clínicos
Malignant Mixed Mullerian Tumor - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus Condición: Mixed Tumor, Mullerian Fecha: 2007-07-16 Intervenciones:
|
Completed |
Nombre del estudio: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma Condición: Uterine Carcinosarcoma Fecha: 2008-05-28 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26 Condición:
|
Not yet recruiting |
Nombre del estudio: Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - Condición: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas Fecha: 2014-05-05 Intervenciones:
|
Completed |
Nombre del estudio: Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus Condición: Mixed Mullerian Tumors of the Uterus Fecha: 2007-05-17 Intervenciones:
|
Completed |
Nombre del estudio: Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus Condición:
Fecha: 2001-10-11 Intervenciones: |
Completed |
Nombre del estudio: Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer Condición:
Fecha: 2010-11-23 Intervenciones: Drug: Pazopanib Hydrochloride Given PO Other Names: |
Active, not recruiting |
Nombre del estudio: Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Condición:
Fecha: 2010-07-22 Intervenciones:
|
Terminated |
Nombre del estudio: Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus Condición:
Fecha: 2010-02-02 Intervenciones: Drug: temsirolimus Given IV Other Names: |
Completed |
Nombre del estudio: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer Condición:
Fecha: 2005-06-13 Intervenciones: |